L Gozzellino, M Nannini, C Pizzi, O Leone, B Corti… - Diagnostics, 2023 - mdpi.com
Primary cardiac sarcomas are considered rare malignant entities associated with poor prognosis. In fact, knowledge regarding their gene signature and possible treatments is still …
M Waldenmaier, L Schulte, J Schönfelder… - 2022 - pdfs.semanticscholar.org
Pancreatic ductal adenocarcinomas (PDACs) are tumors with poor prognosis and limited treatment options. Personalized medicine aims at characterizing actionable DNA variants by …
I Khan, N Masood, A Yasmin - Frontiers in Oncology, 2023 - frontiersin.org
Purpose ERCC5 is a DNA endonuclease and nucleotide excision repair gene; its mutations lead to a lack of activity by this enzyme, causing oxidative DNA damage. This study aimed to …
P Le Van Quyen, N Calmels, M Bonnière… - American Journal of …, 2020 - Wiley Online Library
Cerebro‐oculo‐facio‐skeletal syndrome (COFS) is a rare autosomal recessive neurodegenerative disease belonging to the family of DNA repair disorders, characterized …
TTM Nguyen, LH Huynh, TTN Nguyen… - … Conference on the …, 2022 - Springer
Breast cancer (BC) is the leading cancer-causing death for women worldwide. Among BC- causing genes, ERCC5 plays an important role in DNA damage repair. The cancer risk can …
M Waldenmaier, L Schulte, J Schönfelder… - Cancers, 2022 - mdpi.com
Simple Summary Pancreatic ductal adenocarcinoma (PDAC) has still a dismal prognosis. To improve treatment, personalized medicine uses next-generation DNA sequencing to monitor …
H Zhang, J Wei, Z Liu, X Liu, Y Chong, Y Lu, H Zhao… - bioRxiv, 2020 - biorxiv.org
Motivation Oncogenes are genes whose malfunctions play critical roles in cancer development, and their discovery is a major aim of cancer mechanisms study. By counting …